Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjhemonc logo
VJRegenMed
Logo
  • Home (current)
  • Specialties
    Hematology
    Oncology
    Musculoskeletal Disorder
    Rare Disease
    Metabolic Disorder
    Cardiovascular Disease
    Ophthalmology
    Neurology
    Infectious Disease
    View all Specialties
  • Technologies
    Cell Therapy
    MSC
    iPSC
    Gene Therapy
    Genome Editing
    Extracellular Vesicles
    CAR-T Therapy
    TCR Therapy
    Tissue-Engineering & Biomaterials
    View all Technologies
  • Topics
    Treatment
    Immuno-Oncology
    Trial Updates
    Perspectives
    Manufacturing
    COVID-19
    View all Topics
  • Conferences
    ASH 2022
    TCT 2022
    Meeting on the Med 2022
    ICLE 2022
    Advanced Therapies Week 2022
    TERMIS 2021
    ESGCT 2021
    Meeting on the Mesa 2021
    Advanced Therapies 2021
    View all Conferences
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Tisagenlecleucel

Outcomes of children and young adults with B-ALL following tisa-cel reinfusion 3:52
Outcomes of children and young adults with B-ALL following tisa-cel reinfusion
Kevin McNerney • 24 Feb 2023
Investigating real-world outcomes of patients with R/R LBCL after CD19 CAR-T cell therapy 5:36
Investigating real-world outcomes of patients with R/R LBCL after CD19 CAR-T cell therapy
Veit Buecklein • 9 Dec 2022
Engineering NK cell-based cancer treatments 1:22
Engineering NK cell-based cancer treatments
Juliane Mietz • 1 Apr 2022
Accelerating commercialization in advanced therapies 3:08
Accelerating commercialization in advanced therapies
Pascal Touchon • 7 Apr 2021
An overview of the CAR T-cell therapy story 3:39
An overview of the CAR T-cell therapy story
Mohamad Mohty • 26 Jan 2021
Practical aspects of CAR T-cell therapy 4:14
Practical aspects of CAR T-cell therapy
Ulrich Jäger • 9 Feb 2021
The challenges of CAR T-cell therapy for pediatric B-ALL 4:18
The challenges of CAR T-cell therapy for pediatric B-ALL
Sara Ghorashian • 4 Feb 2021
Updates on CAR T-cell therapy in B-cell malignancies 2:16
Updates on CAR T-cell therapy in B-cell malignancies
Ulrich Jäger • 9 Feb 2021
CAR-T therapy for aggressive B-cell lymphomas 2:42
CAR-T therapy for aggressive B-cell lymphomas
Peter A. Riedell • 2 Sep 2020
Anti-CD19 CAR T-cells for adults 4:51
Anti-CD19 CAR T-cells for adults
David L. Porter • 9 Sep 2020
Real-world efficacy & safety data: CAR-T in DLBCL 3:05
Real-world efficacy & safety data: CAR-T in DLBCL
Matthew Frigault • 1 Sep 2020
Tocilizumab: CAR T-cell therapy in DLBCL 2:18
Tocilizumab: CAR T-cell therapy in DLBCL
Matthew Frigault • 1 Sep 2020
Journal Pages
  • Specialties
  • Technologies
  • Topics
  • Conferences
Newsletter

Receive the latest news and videos from VJRegenMed via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJRegenMed logo
The content of VJRegenMed is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy